InterTabac 2024 Roundup: Spotlight on Leading HNB Brand

Sep.20.2024
InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
InterTabac 2024 enters day two in Dortmund, Germany, with major tobacco companies showcasing their HNB brands.

On September 20, 2024, the InterTabac Tobacco Exhibition in Dortmund, Germany entered its second day. As the official media partner, the 2Firsts team arrived on site to provide comprehensive coverage services.

 

During this exhibition, many companies, including China Tobacco Hong Kong, Philip Morris International (PMI), British American Tobacco (BAT), Smoore, FirstUnion, and others, showcased their HNB brands for the first time.

 

The following is a photo gallery from the scene:

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
China Tobacco Hong Kong booth | Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
PMI showcases its HNB brand IQOS at the exhibition. Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
BAT's HNB brand glo showcases at the exhibition. Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
KT&G booth | Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
SMOORE, with its HNB brand Metex, showcased at the exhibition. Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
REJO booth | Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
MyChoice booth | Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
FirstUnion's Sixhill brand participating in the exhibition with its HNB product line|Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
UWOO booth | Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
ISMOD booth | Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
NEX booth | Image source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
Marskiss booth | Image Source: 2Firsts

 

InterTabac 2024 Roundup: Spotlight on Leading HNB Brand
HITASTE booth | Image source: 2Firsts

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
Wang Gongcheng, deputy administrator of China’s State Tobacco Monopoly Administration, met KT&G Chief Operating Officer Lee Sang-hak in Shanghai on September 1, according to Oriental Tobacco News. The meeting comes as China seeks public comment on a draft mandatory national standard for heated cigarettes. The report did not disclose the subjects discussed or indicate whether heated tobacco products or market access were addressed.
News
Sep.02
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
China's Ministry of Finance and State Taxation Administration announced on October 12, 2026, that value-added tax (VAT) export rebates for vape devices, nicotine and its salts, and certain non-combustible inhalation products will be eliminated from April 1, 2027. The measure adds four tobacco- and nicotine-related customs codes, including 8543400010, which covers vape devices and qualifying empty pods. China previously eliminated rebates for nicotine-containing vaping products and devices under code 8543400090 in April 2026. According to industry classification information held by 2Firsts, the latter currently corresponds to heated tobacco devices. Export excise tax refund and exemption arrangements will remain unchanged.
Special Report
Oct.12
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23